Synergy CHC Corp. (SNYR)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Synergy CHC Corp. (SNYR) trades at $0.20 with AI Score 20/100 (Grade F). Synergy CHC Corp. operates in the consumer health care sector, offering a range of beauty, health, and lifestyle products. Market cap: $2.11M, Sector: Healthcare.
Price live · AI analysis from May 10, 2026Analyst Coverage for SNYR: SNYR does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates SNYR against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
SNYR: 1/1 perspectives are bearish.
How is this calculated? →Synergy CHC Corp. (SNYR) Healthcare & Pipeline Overview
Synergy CHC Corp. provides consumer healthcare, beauty, and lifestyle products, including brain health supplements (FOCUSfactor), lifestyle accessories (Flat Tummy), and anti-aging skincare (Hand MD). The company distributes through retail partnerships, online sales, and television advertising across the United States, Canada, and the United Kingdom.
What Is the Investment Thesis for SNYR?
Synergy CHC Corp. operates in the competitive consumer health and wellness market. With a market capitalization of $2.11M and a negative profit margin of -40.6%, the company faces significant challenges in achieving profitability. Key value drivers include the continued growth of its FOCUSfactor brand in the brain health supplement market and the potential expansion of its Flat Tummy and Hand MD product lines. The company's high gross margin of 66.7% suggests strong pricing power, but operational inefficiencies need to be addressed. Catalysts include potential partnerships with major retailers and successful marketing campaigns. Potential risks include intense competition, changing consumer preferences, and the need for effective brand management. The company's beta of 1.47 indicates higher volatility compared to the market.
Based on FMP financials and quantitative analysis
SNYR Key Highlights
- Gross Margin of 66.7% indicates strong pricing power in the consumer health and beauty market.
- Negative Profit Margin of -40.6% highlights significant challenges in achieving profitability and managing operational costs.
- Market Cap of $2.11M reflects the company's small size and potential growth opportunities.
- Distribution network across the United States, Canada, and the United Kingdom provides a broad market reach.
- FOCUSfactor brand represents a key asset in the growing brain health supplement market.
Who Are SNYR's Competitors?
SNYR is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| HLTH Cue Health Inc. | $0.04 | -29.77% | $6.90M | 44 |
| FEDDX Fidelity Emerging Markets Discovery Fd | $23.32 | +1.83% | $1.53B | 47 |
| DAUG FT Vest U.S. Equity Deep Buffer ETF - August | $47.01 | +0.09% | $363.75M | 47 |
| KSTR KraneShares SSE STAR Market 50 Index ETF | $28.60 | +0.25% | $66.71M | 47 |
| PEQSX Putnam Large Cap Value Fund | $44.15 | +0.46% | $51.63B | 47 |
| FTQGX Fidelity Focused Stock Fund | $48.84 | +1.67% | $5.50B | 44 |
| FIRRX Fidelity Simplicity RMD 2010 Fund | $51.74 | -0.75% | $9.46M | 44 |
| SHAPX ClearBridge Appreciation A | $36.87 | +0.63% | $9.85B | 44 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are SNYR's Key Strengths?
- Established brand recognition for FOCUSfactor.
- Diverse product portfolio across health, beauty, and lifestyle categories.
- Multi-channel distribution network (retail, online, television).
- High gross profit margin.
What Are SNYR's Weaknesses?
- Negative profit margin indicates operational inefficiencies.
- Small market capitalization limits access to capital.
- High beta suggests higher volatility compared to the market.
- Limited geographic presence primarily in the US, Canada, and the UK.
What Could Drive SNYR Stock Higher?
- Potential partnerships with major retailers to expand product distribution.
- Continued growth of the FOCUSfactor brand in the brain health supplement market.
- Implementation of digital marketing strategies to enhance online sales.
What Are the Key Risks for SNYR?
- Financial-distress signal — its Altman Z-Score of -13.06 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 1/9 flags soft profitability, leverage or efficiency.
- Intense competition from established players and emerging brands.
- Changing consumer preferences and demand for natural products.
- Negative profit margin indicates operational inefficiencies.
- Economic downturns impacting consumer spending on discretionary items.
What Are the Growth Opportunities for SNYR?
- Expansion of FOCUSfactor Product Line: The brain health supplement market is experiencing significant growth, driven by increasing awareness of cognitive health and the aging population. Synergy CHC Corp. can capitalize on this trend by expanding its FOCUSfactor product line to include new formulations, delivery methods, and targeted solutions for different age groups and cognitive needs. The global brain health supplements market is projected to reach $13.38 billion by 2028. Timeline: Ongoing.
- Strategic Retail Partnerships: Securing partnerships with major retailers in the United States, Canada, and the United Kingdom can significantly increase Synergy CHC Corp.'s product visibility and accessibility. Collaborating with retailers like Walmart, Target, and Boots can provide access to a broader customer base and enhance brand recognition. These partnerships can drive sales volume and market share. Timeline: Upcoming, within the next 12-24 months.
- Enhanced Online Presence and E-commerce Strategy: Investing in a robust e-commerce platform and digital marketing strategy can improve Synergy CHC Corp.'s online sales and customer engagement. Optimizing the company's website, utilizing social media marketing, and implementing targeted advertising campaigns can attract new customers and drive online revenue. The global e-commerce market is expected to reach $6.3 trillion in 2024. Timeline: Ongoing.
- Product Innovation and New Product Development: Developing innovative and differentiated products can help Synergy CHC Corp. stand out in the competitive consumer health and wellness market. Investing in research and development to create new formulations, address emerging health trends, and cater to specific consumer needs can drive growth and enhance brand loyalty. Timeline: Ongoing.
- Geographic Expansion: Expanding into new geographic markets can provide Synergy CHC Corp. with significant growth opportunities. Targeting countries with growing economies and increasing demand for consumer health and wellness products, such as emerging markets in Asia and Latin America, can drive revenue growth and diversify the company's customer base. Timeline: Potential, within the next 3-5 years.
What Opportunities Does SNYR Have?
- Expansion of FOCUSfactor product line to capture growing brain health market.
- Strategic partnerships with major retailers to increase product visibility.
- Enhanced online presence and e-commerce strategy to drive online sales.
- New product development to address emerging health trends.
What Threats Does SNYR Face?
- Intense competition from established players and emerging brands.
- Changing consumer preferences and demand for natural products.
- Regulatory scrutiny and compliance requirements in the health and wellness industry.
- Economic downturns impacting consumer spending on discretionary items.
What Are SNYR's Competitive Advantages?
- Brand recognition for FOCUSfactor in the brain health supplement market.
- Established distribution network across multiple channels (retail, online, television).
- Proprietary formulations and product development capabilities.
What Does SNYR Do?
Synergy CHC Corp., established in 2010 and based in Westbrook, Maine, focuses on developing and distributing consumer health care, beauty, and lifestyle products. Originally incorporated as Synergy Strips Corp., the company rebranded to Synergy CHC Corp. in August 2015 to reflect its expanded product portfolio. The company's core offerings include brain health nutritional supplements under the FOCUSfactor brand, which aims to enhance cognitive function. Additionally, Synergy CHC Corp. markets lifestyle products and accessories under the Flat Tummy brand, featuring items such as tea, shakes, lollipops, supplements, apparel, and exercise accessories. The company also offers anti-aging skincare products under the Hand MD brand, including serums, creams, hand soaps, and sanitizers designed for skin repair, rehydration, and overall hand care. Synergy CHC Corp. distributes its products through a multi-channel approach, leveraging retailers, television advertising campaigns, and online sales platforms to reach consumers in the United States, Canada, and the United Kingdom. The company aims to cater to health-conscious consumers seeking accessible and effective solutions in the health, beauty, and lifestyle sectors.
What Products and Services Does SNYR Offer?
- Develops and markets brain health nutritional supplements under the FOCUSfactor brand.
- Offers lifestyle products and accessories under the Flat Tummy brand, including teas, shakes, and apparel.
- Provides anti-aging skincare products under the Hand MD brand, such as serums and creams.
- Sells products through retailers in the United States, Canada, and the United Kingdom.
- Utilizes television advertising campaigns to promote its products.
- Distributes skincare products through online channels.
How Does SNYR Make Money?
- Develops and markets consumer health, beauty, and lifestyle products.
- Generates revenue through retail sales, online sales, and television advertising.
- Focuses on brand development and marketing to drive product demand.
What Industry Does SNYR Operate In?
Synergy CHC Corp. operates within the competitive consumer health and wellness industry, which includes dietary supplements, skincare, and lifestyle products. The market is characterized by evolving consumer preferences, increasing demand for natural and organic products, and intense competition from established players and emerging brands. The global dietary supplements market is projected to reach $230.73 billion by 2027, growing at a CAGR of 9.6%. Synergy CHC Corp. competes with companies offering similar products through retail, online, and direct-to-consumer channels. The company's success depends on effective marketing, product innovation, and strategic partnerships to gain market share.
Who Are SNYR's Key Customers?
- Health-conscious consumers seeking brain health supplements.
- Individuals interested in lifestyle products and accessories.
- Consumers looking for anti-aging skincare solutions.
SNYR Valuation & Market Position
With a $2.11M market cap, Synergy CHC Corp. sits in the micro-cap segment of the market. Relative to its peer group, SNYR's quantitative score of 20/100 is below the peer average of 46/100.
FY2026 estForward Outlook
Wall Street analysts project Synergy CHC Corp. revenue of about $32.0M for fiscal 2026, with EPS near $-0.19.
F-Score 1/9Financial Health
Synergy CHC Corp.'s Piotroski F-Score is 1/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -13.06 places it in the distress zone, a signal of elevated financial risk.
ROE 91%Key Financial Metrics
Return on equity for Synergy CHC Corp. stands at 91.3%, a gauge of how efficiently it converts shareholder capital into profit. A current ratio of 0.93 means current liabilities exceed short-term assets, a liquidity point worth watching.
SNYR Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Established brand recognition for FOCUSfactor.
- Diverse product portfolio across health, beauty, and lifestyle categories.
- Multi-channel distribution network (retail, online, television).
- High gross profit margin.
Bear Case
- Negative profit margin indicates operational inefficiencies.
- Small market capitalization limits access to capital.
- High beta suggests higher volatility compared to the market.
- Limited geographic presence primarily in the US, Canada, and the UK.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
SNYR Latest News
-
12 Consumer Staples Stocks Moving In Monday's Pre-Market Session
benzinga · Jun 1, 2026
-
BC-Most Active Stocks
Associated Press · May 28, 2026
-
Why Phreesia Shares Are Trading Higher By 19%; Here Are 20 Stocks Moving Premarket
benzinga · May 28, 2026
-
Synergy CHC Corp Registers Resale Of Up To 101.7M Shares Under Equity Purchase Agreement With Potential $36M In Company Funding
benzinga · May 15, 2026
SNYR Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for SNYR.
Price Targets
Wall Street price target analysis for SNYR.
SNYR MoonshotScore
What does this score mean?
The MoonshotScore rates SNYR's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Latest News
12 Consumer Staples Stocks Moving In Monday's Pre-Market Session
BC-Most Active Stocks
Why Phreesia Shares Are Trading Higher By 19%; Here Are 20 Stocks Moving Premarket
Synergy CHC Corp Registers Resale Of Up To 101.7M Shares Under Equity Purchase Agreement With Potential $36M In Company Funding
Leadership: Jack Ross
CEO
Jack Ross serves as the CEO of Synergy CHC Corp., managing a team of 21 employees. His background includes experience in the consumer health and wellness industry, with a focus on brand management, product development, and sales strategy. He has held various leadership positions in marketing and operations, contributing to the growth and expansion of consumer product companies. Ross's expertise lies in identifying market opportunities, developing innovative products, and building strong distribution networks. He is committed to driving Synergy CHC Corp.'s growth and profitability through strategic initiatives and operational excellence.
Track Record: Under Jack Ross's leadership, Synergy CHC Corp. has focused on expanding its product portfolio and strengthening its distribution channels. Key achievements include the continued growth of the FOCUSfactor brand and the development of new skincare products under the Hand MD brand. Ross has also overseen the implementation of digital marketing strategies to enhance online sales and customer engagement. His strategic decisions have aimed at improving the company's financial performance and market position.
Common Questions About SNYR (Healthcare)
What does Synergy CHC Corp. do?
Synergy CHC Corp. is a consumer health and wellness company that develops, markets, and distributes a range of products across the United States, Canada, and the United Kingdom. The company's product portfolio includes brain health supplements under the FOCUSfactor brand, lifestyle products and accessories under the Flat Tummy brand, and anti-aging skincare products under the Hand MD brand. Synergy CHC Corp. sells its products through retailers, online channels, and television advertising campaigns, targeting health-conscious consumers seeking accessible and effective solutions in the health, beauty, and lifestyle sectors. The company focuses on brand development, product innovation, and strategic partnerships to drive growth and market share.
What do analysts say about SNYR stock?
As of May 10, 2026, there is limited analyst coverage specifically for Synergy CHC Corp. (SNYR) due to its small market capitalization and limited trading volume. Key valuation metrics such as price-to-earnings (P/E) ratio and earnings per share (EPS) are not readily available due to the company's negative profit margin. Investors may want to evaluate the company's growth potential in the brain health supplement and skincare markets, as well as its ability to improve operational efficiencies and achieve profitability. Further research and due diligence are recommended before making any investment decisions.
What are the main risks for SNYR?
Synergy CHC Corp. faces several key risks, including intense competition from established players and emerging brands in the consumer health and wellness market. The company's negative profit margin indicates operational inefficiencies and challenges in achieving profitability. Changing consumer preferences and increasing demand for natural and organic products may require significant product reformulation and marketing efforts. Economic downturns could impact consumer spending on discretionary items, affecting sales of the company's products. Regulatory scrutiny and compliance requirements in the health and wellness industry also pose potential risks.
What are the key factors to evaluate for SNYR?
Synergy CHC Corp. (SNYR) holds an AI score of 20/100 (low). Not financial advice.
How frequently does SNYR data refresh on this page?
SNYR prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven SNYR's recent stock price performance?
Synergy CHC Corp. (SNYR) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Established brand recognition for FOCUSfactor. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider SNYR overvalued or undervalued right now?
Valuing Synergy CHC Corp. (SNYR) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying SNYR?
Before investing in Synergy CHC Corp. (SNYR), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is limited due to the company's small market capitalization.
- Analyst coverage is minimal, requiring independent research.